↓ Skip to main content

Outcome of AIDS-associated cryptococcal meningitis initially treated with 200 mg/day or 400 mg/day of fluconazole

Overview of attention for article published in BMC Infectious Diseases, July 2006
Altmetric Badge

About this Attention Score

  • Average Attention Score compared to outputs of the same age and source

Mentioned by

wikipedia
3 Wikipedia pages

Citations

dimensions_citation
47 Dimensions

Readers on

mendeley
41 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Outcome of AIDS-associated cryptococcal meningitis initially treated with 200 mg/day or 400 mg/day of fluconazole
Published in
BMC Infectious Diseases, July 2006
DOI 10.1186/1471-2334-6-118
Pubmed ID
Authors

CF Schaars, GA Meintjes, C Morroni, FA Post, G Maartens

Abstract

AIDS-associated cryptococcal meningitis has a high mortality. Fluconazole was the only systemic antifungal therapy available in our centre. From 1999-2001 we used low-dose fluconazole (200 mg daily initially), and did not offer therapy to patients perceived to have poor prognoses. In 2001 donated fluconazole became available, allowing us to use standard doses (400 mg daily initially). Antiretroviral therapy was not available during the study period.

Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 41 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Ethiopia 1 2%
Tanzania, United Republic of 1 2%
Unknown 39 95%

Demographic breakdown

Readers by professional status Count As %
Student > Ph. D. Student 8 20%
Other 5 12%
Professor > Associate Professor 4 10%
Student > Bachelor 4 10%
Lecturer 3 7%
Other 14 34%
Unknown 3 7%
Readers by discipline Count As %
Medicine and Dentistry 26 63%
Immunology and Microbiology 4 10%
Agricultural and Biological Sciences 4 10%
Social Sciences 1 2%
Neuroscience 1 2%
Other 0 0%
Unknown 5 12%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 3. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 19 July 2011.
All research outputs
#7,452,489
of 22,783,848 outputs
Outputs from BMC Infectious Diseases
#2,538
of 7,670 outputs
Outputs of similar age
#22,746
of 65,488 outputs
Outputs of similar age from BMC Infectious Diseases
#3
of 12 outputs
Altmetric has tracked 22,783,848 research outputs across all sources so far. This one is in the 44th percentile – i.e., 44% of other outputs scored the same or lower than it.
So far Altmetric has tracked 7,670 research outputs from this source. They typically receive more attention than average, with a mean Attention Score of 9.6. This one has gotten more attention than average, scoring higher than 62% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 65,488 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 15th percentile – i.e., 15% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 12 others from the same source and published within six weeks on either side of this one. This one is in the 33rd percentile – i.e., 33% of its contemporaries scored the same or lower than it.